Our Compounding

Therapeutic Category:

Antiemetic, 5-HT3 Receptor Antagonist

Key Ingredients:

Ondansetron is a selective 5-HT3-receptors antagonist which blocks serotonin, both peripherally on vagal nerve terminals and centrally in the chemo-receptors triggers zone

Formulation Strength:

Ondansetron Suspension 0.8/ml

PEDIATRIC ORAL

• Prevention of Chemotherapy-induced nausea and vomiting
• Treatment of acute gastroenteritis
• Prevention of radiation-induced nausea and vomiting

Oral (all dosage forms): May administer without regard to meals. Administer 30 minutes prior to chemotherapy, 1 to 2 hour prior to radiotherapy, and 1 hour prior to induction of anesthesia